BUZZ-Revolution Medicines plunges after report Merck no longer in buyout talks

Merck & Co., Inc. +0.02%
Revolution Medicines +0.49%

Merck & Co., Inc.

MRK

120.87

+0.02%

Revolution Medicines

RVMD

99.12

+0.49%

** Cancer drug developer Revolution Medicines' RVMD.O shares fall 22.8% to $90.76 premarket

** Wall Street Journal reports Merck MRK.N is no longer in discussions to buy RVMD

** The talks cooled after the two could not agree on price - WSJ

** RVMD shares jumped 10% after the talks for a $28 billion to $32 billion buyout were first reported

** RVMD stock gained 82% in last year


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.